{"category":{"kind":"industry","slug":"oncology","name":"Oncology","tagline":null,"description":null,"synonyms":[],"target_queries":[],"added_via":"pr","added_at":"2026-09-03T05:53:03.969Z","updated_at":"2026-09-03T05:53:03.969Z","example":false,"profile_url":"/industries/oncology","is_stub":true,"member_count":21,"member_counts":{"accelerator":1,"company":20}},"members":[{"listing_type":"company","name":"Solstice Oncology","slug":"solstice-oncology","tagline":"Neoadjuvant immuno-oncology therapies designed to improve cure rates","description":"Solstice Oncology is a Boston clinical-stage immuno-oncology company developing porustobart, an engineered CTLA-4 antibody, in combination with anti–PD-1 therapy for neoadjuvant treatment of early-stage cancers, beginning with MSS stage III colon cancer. Led by CEO Caroline J. Loew. Public site: solsticeoncology.com.","url":"https://www.solsticeoncology.com/","is_stealth":false,"normalized_domain":"solsticeoncology.com","normalized_url_key":"solsticeoncology.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://images.squarespace-cdn.com/content/v1/6a6c9ce51d9c4447456022a0/b1803ba3-9069-49f7-b0f9-1da916cefd56/favicon.ico","links":[{"label":"X / Twitter","url":"https://x.com/SolsticeOnc","platform":"x"}],"entry_points":[{"kind":"homepage","url":"https://www.solsticeoncology.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.solsticeoncology.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[{"name":"Caroline J. Loew","role":"President and CEO","person_slug":"caroline-j-loew-1egiu4nxlbbce","bio":null,"location":null,"links":[]}],"media":{"logo_asset_id":"14d98e23-24cd-401f-8b2d-d020642e89bd"},"categories":["Biotech","Health","Oncology"],"stage":null,"founded_year":null,"location":"Boston, MA","pricing":null,"twitter":"https://x.com/SolsticeOnc","github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-10T08:20:47.746Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-10T08:20:47.746Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"health","name":"Health","note":null,"profile_url":"/industries/health"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-10T08:20:47.746Z","updated_at":"2026-09-10T08:20:47.746Z"}},{"listing_type":"company","name":"Gamgee","slug":"gamgee","tagline":"Scalable Personalised Cancer Treatment","description":"​Gamgee began with Rosie, founder Paul Conyngham’s dog. After surgery, chemotherapy and immunotherapy failed, Rosie was given months to live. Paul used AI and genomic analysis to identify targets in her tumour, then worked with scientists at UNSW to produce what is believed to be the first fully computationally designed mRNA cancer vaccine delivered to a dog. Following treatment, several tumours shrank significantly and her quality of life improved\n\nGamgee is building an end to end platform for personalised mRNA cancer vaccines for dogs. We sequence a dog’s tumour and healthy DNA, identify mutations unique to its cancer, and design a vaccine that teaches the immune system what to attack. We manage the entire process- from vet intake and tissue collection through genomic analysis, vaccine production, treatment and response monitoring\n\n​We are now turning that one off effort into a repeatable clinical system. Gamgee is running clinical trials in Australia, working with vets, oncologists and specialised laboratories, and accepting cases globally. Our goal is to make personalised cancer treatment accessible to every dog that needs it- and use each case to improve the treatment for the next\n\nGamgee is a Y Combinator company (Summer 2026). YC-listed status: Active.","url":"https://www.gamgee.io/","is_stealth":false,"normalized_domain":"gamgee.io","normalized_url_key":"gamgee.io","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/6f6bf83f60f82f47f1a3b961153608810edebb3b.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/gamgee","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.gamgee.io/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.gamgee.io/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Biotech","Genomics","Oncology","AI"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; Remote","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T08:33:26.675Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2026","Biotech","Genomics","Oncology","AI"],"one_liner_for_search":"Gamgee — Scalable Personalised Cancer Treatment (Y Combinator Summer 2026)","canonical_facts":["Y Combinator batch: Summer 2026","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Former names: Gamgee Technologies","Regions (per YC): United States of America, America / Canada, Remote, Fully Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T08:33:26.675Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"genomics","name":"Genomics","note":null,"profile_url":"/industries/genomics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T08:33:26.675Z","updated_at":"2026-09-03T08:33:26.675Z"}},{"listing_type":"company","name":"Omanta","slug":"omanta","tagline":"A research lab for one","description":"Omanta is a personalized research lab for patients who have exhausted standard options, want to prepare proactively for recurrence, or are living with an unresolved diagnosis.\n\nWe direct the full operational infrastructure, personnel, expertise, and technology of a large research program toward understanding and addressing the challenges of individual patients across oncology, rare disease, and undiagnosed conditions.\n\nFor clinicians, we act as a collaborative partner, providing a living roadmap for ongoing patient care built on a rigorous and evolving scientific evidence base.\n\nWe fully operationalize patient-specific research programs, covering tissue logistics, diagnostic follow-up, data integration, multiomic analysis, therapeutic strategy development, and more.\n\nOmanta brings context and clarity to complex cases, helping clinicians see more of the scientific picture as they decide how best to care for their patients.\n\nOmanta is a Y Combinator company (Summer 2026). YC-listed status: Active.","url":"https://omanta.com/","is_stealth":false,"normalized_domain":"omanta.com","normalized_url_key":"omanta.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/ae1812a6e6a806880355a25e542d3970bd58deb5.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/omanta","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://omanta.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://omanta.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Digital Health","Health & Wellness","Oncology","AI"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T08:32:33.667Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2026","Digital Health","Healthcare","Health & Wellness","Oncology","AI"],"one_liner_for_search":"Omanta — A research lab for one (Y Combinator Summer 2026)","canonical_facts":["Y Combinator batch: Summer 2026","YC company status: Active","Team size (per YC directory): 5","YC industry: Healthcare","YC subindustry: Healthcare","Former names: ClinSIGHT AI","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T08:32:33.667Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai","name":"AI","note":null,"profile_url":"/industries/ai"},{"kind":"industry","slug":"digital-health","name":"Digital Health","note":null,"profile_url":"/industries/digital-health"},{"kind":"industry","slug":"health-and-wellness","name":"Health & Wellness","note":null,"profile_url":"/industries/health-and-wellness"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T08:32:33.667Z","updated_at":"2026-09-03T08:32:33.667Z"}},{"listing_type":"company","name":"Kopra Bio","slug":"kopra-bio","tagline":"Genetically engineered viruses that teach your immune system to kill…","description":"Kopra Bio makes genetically engineered viruses that teach your immune system to kill cancer using tech we developed at UCSF. We’re making the next Keytruda ($25B/yr cancer drug blockbuster) starting with the most aggressive form of brain cancer, glioblastoma. In the most challenging brain cancer model, we improve survival from 0% with the current FDA approved treatment to 90% with our treatment.\n\nKopra Bio is a Y Combinator company (Summer 2024). YC-listed status: Active.","url":"https://www.kopra.bio/","is_stealth":false,"normalized_domain":"kopra.bio","normalized_url_key":"kopra.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/acdb0c2a3124d9e5717a63d0231af9b6f7447919.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/kopra-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.kopra.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.kopra.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","Synthetic Biology","Biotech","Oncology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:49:28.291Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2024","Gene Therapy","Synthetic Biology","Biotech","Therapeutics","Oncology"],"one_liner_for_search":"Kopra Bio — Genetically engineered viruses that teach your immune system to kill… (Y Combinator Summer 2024)","canonical_facts":["Y Combinator batch: Summer 2024","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: GlioTx","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:49:28.291Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:49:28.291Z","updated_at":"2026-09-03T07:49:28.291Z"}},{"listing_type":"company","name":"Granza Bio","slug":"granza-bio","tagline":"Building programmable therapeutics for the immune system","description":"Granza Bio is developing programmable therapeutics for the immune system. Our platform is built on the foundational discovery of immune “superkiller” attack particles — the natural ammunition used by cytotoxic immune cells to deliver potent, localized killing. By re-arming exhausted immune cells with newly programmed ammunition, Granza restores and enhances immune function. This approach enables a new class of treatments with the potential to transform diseases ranging from cancer to autoimmunity.\n\nGranza Bio is a Y Combinator company (Winter 2024). YC-listed status: Active.","url":"https://www.granzabio.com/","is_stealth":false,"normalized_domain":"granzabio.com","normalized_url_key":"granzabio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/e4fe5f43800f16c0ca16303f58b955037e3f2bc1.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/granza-bio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.granzabio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.granzabio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Synthetic Biology","Biotech","Oncology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:45:07.063Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2024","Synthetic Biology","Biotech","Healthcare","Therapeutics","Oncology"],"one_liner_for_search":"Granza Bio — Building programmable therapeutics for the immune system (Y Combinator Winter 2024)","canonical_facts":["Y Combinator batch: Winter 2024","YC company status: Active","Team size (per YC directory): 8","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Zyme Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:45:07.063Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:45:07.063Z","updated_at":"2026-09-03T07:45:07.063Z"}},{"listing_type":"company","name":"Eris Biotech","slug":"eris-biotech","tagline":"Our drugs engage the immune system to fight tumors","description":"We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.\n\nEris Biotech is a Y Combinator company (Winter 2024). YC-listed status: Active.","url":"https://www.erisbio.com/","is_stealth":false,"normalized_domain":"erisbio.com","normalized_url_key":"erisbio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/b16bbab6bd8003573ebc3410a08531b90c3427fd.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/eris-biotech","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.erisbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.erisbio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Biotech","Drug discovery","Oncology"],"stage":null,"founded_year":null,"location":"Lehi, UT, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:44:18.257Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2024","Biotech","Therapeutics","Drug discovery","Oncology"],"one_liner_for_search":"Eris Biotech — Our drugs engage the immune system to fight tumors (Y Combinator Winter 2024)","canonical_facts":["Y Combinator batch: Winter 2024","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:44:18.257Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:44:18.257Z","updated_at":"2026-09-03T07:44:18.257Z"}},{"listing_type":"company","name":"Velorum Therapeutics","slug":"velorum-therapeutics","tagline":"Breakthrough medicines unlocking the biology of heme","description":"Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.\n\nVelorum Therapeutics is a Y Combinator company (Winter 2024). YC-listed status: Active.","url":"https://www.velorumtx.com/","is_stealth":false,"normalized_domain":"velorumtx.com","normalized_url_key":"velorumtx.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/f201fcf7f4408f2acdedabe7f9bef2baabec8369.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/velorum-therapeutics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.velorumtx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.velorumtx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Biotech","Drug discovery","Oncology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:43:18.066Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2024","Biotech","Healthcare","Therapeutics","Drug discovery","Oncology"],"one_liner_for_search":"Velorum Therapeutics — Breakthrough medicines unlocking the biology of heme (Y Combinator Winter 2024)","canonical_facts":["Y Combinator batch: Winter 2024","YC company status: Active","Team size (per YC directory): 5","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:43:18.066Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:43:18.066Z","updated_at":"2026-09-03T07:43:18.066Z"}},{"listing_type":"company","name":"SynsoryBio","slug":"synsorybio","tagline":"\"If-then\" conditional logic for protein drugs","description":"SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.\n\nSynsoryBio is a Y Combinator company (Winter 2024). YC-listed status: Active.","url":"https://www.synsorybio.com/","is_stealth":false,"normalized_domain":"synsorybio.com","normalized_url_key":"synsorybio.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/e2b7538a15335c79e864ff7431e761c3feca0797.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/synsorybio","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.synsorybio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.synsorybio.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Synthetic Biology","Biotech","Oncology"],"stage":null,"founded_year":null,"location":"Boston, MA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:39:17.707Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2024","Synthetic Biology","Biotech","Therapeutics","Oncology"],"one_liner_for_search":"SynsoryBio — \"If-then\" conditional logic for protein drugs (Y Combinator Winter 2024)","canonical_facts":["Y Combinator batch: Winter 2024","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:39:17.707Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:39:17.707Z","updated_at":"2026-09-03T07:39:17.707Z"}},{"listing_type":"company","name":"Modulari-T","slug":"modulari-t","tagline":"We teach your immune system to attack and cure cancer","description":"Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise.\n\nModulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue.\n\nModulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.\n\nModulari-T is a Y Combinator company (Winter 2023). YC-listed status: Active.","url":"https://modularit.bio/","is_stealth":false,"normalized_domain":"modularit.bio","normalized_url_key":"modularit.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/cdfde836f1d168c7ec0299ab6b4daf90d112f929.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/modulari-t","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://modularit.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://modularit.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Gene Therapy","Cell Therapy","Synthetic Biology","Biotech","Oncology"],"stage":null,"founded_year":null,"location":"Montreal, QC, Canada; San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:28:22.865Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2023","Gene Therapy","Cell Therapy","Synthetic Biology","Biotech","Oncology"],"one_liner_for_search":"Modulari-T — We teach your immune system to attack and cure cancer (Y Combinator Winter 2023)","canonical_facts":["Y Combinator batch: Winter 2023","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Modulari-T Biosciences","Regions (per YC): Canada, United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:28:22.865Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/industries/cell-therapy"},{"kind":"industry","slug":"gene-therapy","name":"Gene Therapy","note":null,"profile_url":"/industries/gene-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:28:22.865Z","updated_at":"2026-09-03T07:28:22.865Z"}},{"listing_type":"company","name":"Adventris Pharmaceuticals","slug":"adventris-pharmaceuticals","tagline":"Adventris makes cancer vaccines","description":"Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first \"off-the-shelf\" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths.\n\nIf you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at contact@adventris.com\n\nAdventris Pharmaceuticals is a Y Combinator company (Winter 2023). YC-listed status: Active.","url":"https://www.adventris.com/","is_stealth":false,"normalized_domain":"adventris.com","normalized_url_key":"adventris.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/5c8bb0a987c29df94410bb9cc6ab7db9eb0d6478.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/adventris-pharmaceuticals","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.adventris.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.adventris.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","Biotech","Therapeutics","Drug discovery","Oncology"],"stage":null,"founded_year":null,"location":"Baltimore, MD, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:28:14.694Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2023","Biotech","Healthcare","Therapeutics","Drug discovery","Oncology"],"one_liner_for_search":"Adventris Pharmaceuticals — Adventris makes cancer vaccines (Y Combinator Winter 2023)","canonical_facts":["Y Combinator batch: Winter 2023","YC company status: Active","Team size (per YC directory): 7","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Former names: Elimivax","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:28:14.694Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:28:14.694Z","updated_at":"2026-09-03T07:28:14.694Z"}},{"listing_type":"company","name":"Serinus Biosciences","slug":"serinus-biosciences","tagline":"Combinations therapy by rational design","description":"Serinus Biosciences is tackling one of the toughest problems in cancer treatment: creating combination therapies to override treatment resistance. We leverage cutting edge technology to design a fully explainable AI platform primed with decades of system biology knowledge. Uniquely powered for biological inference, our AI engine uncovers how cancer cells evolve treatment resistance and identifies molecules to overcome resistance escape routes. We design combinations that are safer, more effective, and can get to patients quickly. Founded by MIT PhDs and supported by a scientific advisory board of top academics from the Broad Institute, Dana-Farber, and UCSD, Serinus is powered by Y Combinator and other top investors to revolutionize precision medicine.\n\nSerinus Biosciences is a Y Combinator company (Summer 2022). YC-listed status: Active.","url":"https://www.serinus.bio/","is_stealth":false,"normalized_domain":"serinus.bio","normalized_url_key":"serinus.bio","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/b6e7bac94ec8bfc7378ed11602bae7ea50215536.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/serinus-biosciences","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.serinus.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.serinus.bio/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Biotech","Oncology"],"stage":null,"founded_year":null,"location":"New York City, NY, USA; New York, NY, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:14:13.371Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2022","Biotech","Therapeutics","Oncology"],"one_liner_for_search":"Serinus Biosciences — Combinations therapy by rational design (Y Combinator Summer 2022)","canonical_facts":["Y Combinator batch: Summer 2022","YC company status: Active","Team size (per YC directory): 6","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Serinus","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:14:13.371Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:14:13.371Z","updated_at":"2026-09-03T07:14:13.371Z"}},{"listing_type":"company","name":"Eugit Therapeutics","slug":"eugit-therapeutics","tagline":"Enabling Tissue Targeting of Therapies","description":"Eugit Therapeutics targets the issue of non-specific drugs that cause toxicity and clinical trial failures, affecting millions with tissue-specific inflammatory diseases. TAGHOME delivers drugs with precision to diseased tissues using T cell receptors, enhancing safety and improving efficacy. Our initial focus is on the 3.1 million U.S. individuals with Inflammatory Bowel Disease, aiming to initiate clinical trials within two years.\n\nCofounded by George Church (Harvard) and funded by Y Combinator (S22).\n\nEugit Therapeutics is a Y Combinator company (Summer 2022). YC-listed status: Active.","url":"https://www.eugittx.com/","is_stealth":false,"normalized_domain":"eugittx.com","normalized_url_key":"eugittx.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/a88b74cc086730f852f068c605f2dcaa54b40a16.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/eugit-therapeutics","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.eugittx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.eugittx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Cell Therapy","Synthetic Biology","Oncology","Biotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; South San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:11:22.895Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2022","Cell Therapy","Synthetic Biology","Therapeutics","Oncology","Biotechnology"],"one_liner_for_search":"Eugit Therapeutics — Enabling Tissue Targeting of Therapies (Y Combinator Summer 2022)","canonical_facts":["Y Combinator batch: Summer 2022","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: EUGIT Tx, EUGIT Therapeutics, Eugit, Eugit Therapeutics Inc","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:11:22.895Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"cell-therapy","name":"Cell Therapy","note":null,"profile_url":"/industries/cell-therapy"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"synthetic-biology","name":"Synthetic Biology","note":null,"profile_url":"/industries/synthetic-biology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:11:22.895Z","updated_at":"2026-09-03T07:11:22.895Z"}},{"listing_type":"company","name":"Alixia","slug":"alixia","tagline":"Targeting the Tumor Ecosystem to address cancer drug resistance.","description":"Our compounds disrupt the metabolic and\ninflammatory triggers in both cancer and quasi-cancerous\ncells in the tumor microenvironment. By impacting multiple cell\ntypes, we are enabling effective, lasting cancer treatments.\n\nAlixia is a Y Combinator company (Winter 2022). YC-listed status: Active.","url":"https://www.alixia.com/","is_stealth":false,"normalized_domain":"alixia.com","normalized_url_key":"alixia.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/ff4093c59629c7638e73b36eb069911e0922c140.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/alixia","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.alixia.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.alixia.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Therapeutics","Biotech","Drug discovery","Oncology","Biotechnology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T07:03:09.927Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2022","Biotech","Therapeutics","Drug discovery","Oncology","Biotechnology"],"one_liner_for_search":"Alixia — Targeting the Tumor Ecosystem to address cancer drug resistance. (Y Combinator Winter 2022)","canonical_facts":["Y Combinator batch: Winter 2022","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Therapeutics","Former names: Guided Clarity","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T07:03:09.927Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"biotechnology","name":"Biotechnology","note":null,"profile_url":"/industries/biotechnology"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/industries/therapeutics"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T07:03:09.927Z","updated_at":"2026-09-03T07:03:09.927Z"}},{"listing_type":"company","name":"REPROSENT","slug":"reprosent","tagline":"Activating an overlooked force in medicine - the patient.","description":"REPROSENT is a patient-driven care system that harnesses patients' time to relieve overburdened medical teams. With an app that elevates the role of both patients and their loved ones, REPROSENT helps patients stay on track, capture previously untapped data about their lived experience, and receive timely triage that improves their health outcomes. By making crucial patient information actionable, REPROSENT enables doctors to focus their time on personalized treatment, transforming the way medical care is provided.\n\nREPROSENT is a Y Combinator company (Summer 2021). YC-listed status: Active.","url":"https://www.reprosent.com/","is_stealth":false,"normalized_domain":"reprosent.com","normalized_url_key":"reprosent.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/70401adb14eed7e643c2ec631d7664fd02af2167.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/reprosent","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.reprosent.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.reprosent.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Biometrics","Consumer Health Services","Digital Health","Oncology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; Los Gatos, CA, USA; Remote","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:50:23.534Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2021","Biometrics","Consumer Health Services","Digital Health","Healthcare","Oncology"],"one_liner_for_search":"REPROSENT — Activating an overlooked force in medicine - the patient. (Y Combinator Summer 2021)","canonical_facts":["Y Combinator batch: Summer 2021","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare","Former names: Reprosent","Regions (per YC): United States of America, America / Canada, Remote, Fully Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:50:23.534Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"biometrics","name":"Biometrics","note":null,"profile_url":"/industries/biometrics"},{"kind":"industry","slug":"consumer-health-services","name":"Consumer Health Services","note":null,"profile_url":"/industries/consumer-health-services"},{"kind":"industry","slug":"digital-health","name":"Digital Health","note":null,"profile_url":"/industries/digital-health"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:50:23.534Z","updated_at":"2026-09-03T06:50:23.534Z"}},{"listing_type":"company","name":"Zealth","slug":"zealth","tagline":"Software for remote monitoring of cancer patients","description":"Zealth is building remote monitoring software to help hospitals provide automated continuous round-the-clock support to their cancer patients post-discharge. \n\nHospitals are overburdened with no resources to provide care to their chronic patients once they leave the hospital. For instance, in India, there are only 2200 oncologists for 1.38 billion people. Patients travel 100 miles waiting for hours to get few minutes with the doctors. They have no easy means to manage all the toxicities and symptoms they get once they are back home. This leads to 6X lower patient retention, 4X high emergency readmissions, and poor patient outcomes. \n\nZealth bridges this gap through its digital health intervention platform.\n\nZealth is a Y Combinator company (Winter 2021). YC-listed status: Active.","url":"https://www.zealth-ai.com/","is_stealth":false,"normalized_domain":"zealth-ai.com","normalized_url_key":"zealth-ai.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/18c9dca3fe4fe586ecc86e321177f271f61a4ffb.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/zealth","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.zealth-ai.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.zealth-ai.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Healthcare IT","Health Tech","Remote","Oncology"],"stage":null,"founded_year":null,"location":"Bengaluru, KA, India; Remote","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:44:32.834Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2021","Health Tech","Remote","Oncology"],"one_liner_for_search":"Zealth — Software for remote monitoring of cancer patients (Y Combinator Winter 2021)","canonical_facts":["Y Combinator batch: Winter 2021","YC company status: Active","Team size (per YC directory): 2","YC industry: Healthcare","YC subindustry: Healthcare / Healthcare IT","Regions (per YC): India, South Asia, Remote, Fully Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:44:32.834Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"health-tech","name":"Health Tech","note":null,"profile_url":"/industries/health-tech"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"healthcare-it","name":"Healthcare IT","note":null,"profile_url":"/industries/healthcare-it"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"remote","name":"Remote","note":null,"profile_url":"/industries/remote"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:44:32.834Z","updated_at":"2026-09-03T06:44:32.834Z"}},{"listing_type":"company","name":"Known Medicine","slug":"known-medicine","tagline":"Combining 3D cell culture & AI to translate drugs to clinical success","description":"Known Medicine combines patient-specific 3D cell culture & AI to translate drugs to clinical success. We receive patient tumors, break them down, make thousands of micro-tumors, and then treat each with different drugs to determine which they will respond best to.\n\nKnown Medicine is a Y Combinator company (Summer 2020). YC-listed status: Acquired.","url":"https://www.knownmed.com/","is_stealth":false,"normalized_domain":"knownmed.com","normalized_url_key":"knownmed.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/64559b981b2b0426448690c07d39ec63246c6492.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/known-medicine","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://www.knownmed.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.knownmed.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","AI-powered Drug Discovery","Oncology"],"stage":null,"founded_year":null,"location":"Salt Lake City, UT, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:34:08.515Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2020","AI-powered Drug Discovery","Oncology"],"one_liner_for_search":"Known Medicine — Combining 3D cell culture & AI to translate drugs to clinical success (Y Combinator Summer 2020)","canonical_facts":["Y Combinator batch: Summer 2020","YC company status: Acquired","Team size (per YC directory): 17","YC industry: Healthcare","YC subindustry: Healthcare","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:34:08.515Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/industries/ai-powered-drug-discovery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:34:08.515Z","updated_at":"2026-09-03T06:34:08.515Z"}},{"listing_type":"company","name":"Clear Gene","slug":"clear-gene","tagline":"Our tests help eradicate cancer by telling doctors whether they got…","description":"Our tests help eradicate cancer by telling doctors whether they got…\n\nClear Gene is a Y Combinator company (Summer 2018). YC-listed status: Active.","url":"https://cleargene.com/","is_stealth":false,"normalized_domain":"cleargene.com","normalized_url_key":"cleargene.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/4c3988b74387b722e9f7364d78e224dbb7a5e2f7.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/clear-gene","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://cleargene.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://cleargene.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Diagnostics","Women's Health","Oncology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; San Carlos, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:16:03.634Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2018","Healthcare","Diagnostics","Women's Health","Oncology"],"one_liner_for_search":"Clear Gene — Our tests help eradicate cancer by telling doctors whether they got… (Y Combinator Summer 2018)","canonical_facts":["Y Combinator batch: Summer 2018","YC company status: Active","Team size (per YC directory): 4","YC industry: Healthcare","YC subindustry: Healthcare / Diagnostics","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:16:03.634Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"},{"kind":"industry","slug":"womens-health","name":"Women's Health","note":null,"profile_url":"/industries/womens-health"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:16:03.634Z","updated_at":"2026-09-03T06:16:03.634Z"}},{"listing_type":"company","name":"FidoCure®","slug":"fidocure","tagline":"FidoCure® is the leader in Precision Medicine for Canine Oncology.","description":"Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine. \n\nFidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics. \n\nOur veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US.\n\nTogether, we can combat canine cancer!\n\nFidoCure® is a Y Combinator company (Winter 2018). YC-listed status: Active.","url":"https://fidocure.com/","is_stealth":false,"normalized_domain":"fidocure.com","normalized_url_key":"fidocure.com","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/bb9e634002d538d6dc6ede0e890087fb0447eb9b.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/fidocure","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://fidocure.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://fidocure.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Healthcare Services","Oncology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA; Palo Alto, CA, USA; Remote","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:14:27.872Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2018","Oncology"],"one_liner_for_search":"FidoCure® — FidoCure® is the leader in Precision Medicine for Canine Oncology. (Y Combinator Winter 2018)","canonical_facts":["Y Combinator batch: Winter 2018","YC company status: Active","Team size (per YC directory): 14","YC industry: Healthcare","YC subindustry: Healthcare / Healthcare Services","Former names: The One Health Company, FidoCure","Regions (per YC): United States of America, America / Canada, Remote, Fully Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:14:27.872Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"healthcare-services","name":"Healthcare Services","note":null,"profile_url":"/industries/healthcare-services"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:14:27.872Z","updated_at":"2026-09-03T06:14:27.872Z"}},{"listing_type":"company","name":"Oncobox","slug":"oncobox","tagline":"Finding the right cancer drug for each patient.","description":"Oncobox believes that many late-stage cancer patients are dying prematurely because doctors lack a data-driven tool to help them decide which drugs currently on the market would most effectively fight individual patients’ specific cancers. That’s where Oncobox comes in. Oncobox is low-cost personalized genetic profiling to help doctors decide which drug to use. In a recent study conducted by leading cancer researchers in Europe and Asia on 900 patients with various late-stage cancers, Oncobox increased the effectiveness of targeted therapies from 25% to 64%.\n\nHow does Oncobox work? Over 150 targeted cancer drugs are currently on the market. But deciding which of these drugs to give to late-stage cancer patients is not a simple task. Cancer doctors are in a race against the clock. They don’t always know which medication will be most effective for their patients. Because these drugs are expensive and typically have significant side effects, they can’t just try them all. Because of these barriers, targeted cancer therapies are effective only 25% of the time, and 70% of patients with late-stage cancers die due to the toxic side effects of ineffective drugs.\n\nOncobox Dx analyses tumor DNA, RNA, and molecular pathways using algorithms to distinguish which molecular targets are the most crucial for individual cases. Doctors receive a clinically actionable report that shows them which drugs are likely to be most effective on the patient.\n\nWe actively seek partners from pharma, hospitals/clinicians, payers, and genomic centers. Feel free to contact us at hello@oncobox.com. \n\nOur team and the scientific advisory board consisting of leading scientists and researchers from UCLA, Stanford, Johns Hopkins University, Boston University, Tufts University, and Rutgers University.\n\nOncobox is a Y Combinator company (Summer 2017). YC-listed status: Active.","url":"https://oncobox.com/","is_stealth":false,"normalized_domain":"oncobox.com","normalized_url_key":"oncobox.com","parent_slug":null,"parent":null,"type_data":{},"logo":null,"links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/oncobox","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://oncobox.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://oncobox.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Diagnostics","Drug discovery","Oncology"],"stage":null,"founded_year":null,"location":"Walnut, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T06:09:35.609Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Summer 2017","Drug discovery","Oncology"],"one_liner_for_search":"Oncobox — Finding the right cancer drug for each patient. (Y Combinator Summer 2017)","canonical_facts":["Y Combinator batch: Summer 2017","YC company status: Active","Team size (per YC directory): 11","YC industry: Healthcare","YC subindustry: Healthcare / Diagnostics","Former names: Oncobox, OncoBox","Regions (per YC): United States of America, America / Canada"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T06:09:35.609Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"diagnostics","name":"Diagnostics","note":null,"profile_url":"/industries/diagnostics"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T06:09:35.609Z","updated_at":"2026-09-03T06:09:35.609Z"}},{"listing_type":"company","name":"Numerion Labs","slug":"numerion-labs","tagline":"Artificial intelligence for drug discovery.","description":"Numerion Labs is an AI-native company accelerating the discovery of life-saving medicines through the development and use of cutting-edge machine learning algorithms. The company unites computational chemistry, structural biology, and medicinal chemistry to pioneer the next generation of AI-driven drug discovery platforms.\n\nNumerion Labs is a Y Combinator company (Winter 2015). YC-listed status: Active.","url":"https://numerionlabs.ai/","is_stealth":false,"normalized_domain":"numerionlabs.ai","normalized_url_key":"numerionlabs.ai","parent_slug":null,"parent":null,"type_data":{},"logo":"https://bookface-images.s3.amazonaws.com/small_logos/c3b218096497a702becc32895ca1b21c4cae78bd.png","links":[{"label":"Y Combinator profile","url":"https://www.ycombinator.com/companies/numerion-labs","platform":"ycombinator"}],"entry_points":[{"kind":"homepage","url":"https://numerionlabs.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://numerionlabs.ai/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Healthcare","Drug Discovery and Delivery","AI-powered Drug Discovery","Deep Learning","Biotech","Drug discovery","Oncology"],"stage":null,"founded_year":null,"location":"San Francisco, CA, USA","pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-03T05:53:03.969Z","added_via":"web","geo":{"keywords":["Y Combinator","YC Winter 2015","AI-powered Drug Discovery","Deep Learning","Biotech","Drug discovery","Oncology"],"one_liner_for_search":"Numerion Labs — Artificial intelligence for drug discovery. (Y Combinator Winter 2015)","canonical_facts":["Y Combinator batch: Winter 2015","YC company status: Active","Team size (per YC directory): 67","YC industry: Healthcare","YC subindustry: Healthcare / Drug Discovery and Delivery","Former names: Atomwise","Regions (per YC): United States of America, America / Canada, Remote, Partly Remote"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-03T05:53:03.969Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"ai-powered-drug-discovery","name":"AI-powered Drug Discovery","note":null,"profile_url":"/industries/ai-powered-drug-discovery"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"deep-learning","name":"Deep Learning","note":null,"profile_url":"/industries/deep-learning"},{"kind":"industry","slug":"drug-discovery","name":"Drug discovery","note":null,"profile_url":"/industries/drug-discovery"},{"kind":"industry","slug":"drug-discovery-and-delivery","name":"Drug Discovery and Delivery","note":null,"profile_url":"/industries/drug-discovery-and-delivery"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-03T05:53:03.969Z","updated_at":"2026-09-03T05:53:03.969Z"}},{"listing_type":"accelerator","name":"TMCi HealthTech Accelerator","slug":"tmci-healthtech-accelerator","tagline":"A six-month Houston-based accelerator connecting global medtech startups with the world's largest medical complex for clinical validation, regulatory…","description":"TMC Innovation (TMCi) runs the HealthTech Accelerator, a six-month program based at the TMC Innovation Factory in Houston, Texas. Now in its 19th cohort (2025), the program brings 10–11 global medtech startups into the heart of the Texas Medical Center, connecting them with researchers, hospital experts, and clinical trial opportunities. The curriculum covers regulatory strategy, data security, hospital procurement, IP, fundraising, and marketing, culminating in a comprehensive go-to-market plan. TMCi also runs Biodesign and Cancer Therapeutics accelerator programs.\n\nProgram duration: 6 months.","url":"https://www.tmc.edu/innovation/","is_stealth":false,"normalized_domain":"tmc.edu","normalized_url_key":"tmc.edu","parent_slug":null,"parent":null,"type_data":{"application_url":"https://www.tmc.edu/innovation/healthtech-accelerator/","application_status":"rolling","formats":["In person"],"focus_areas":["MedTech","Digital Health","AI in Healthcare","Biomedical Engineering","Oncology"],"cohort_frequency":"multiple cohorts per year","portfolio_url":"https://www.tmc.edu/innovation/portfolio/"},"logo":null,"links":[{"label":"Apply","url":"https://www.tmc.edu/innovation/healthtech-accelerator/","platform":"apply"}],"entry_points":[{"kind":"homepage","url":"https://www.tmc.edu/innovation/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},{"kind":"apply","url":"https://www.tmc.edu/innovation/healthtech-accelerator/","audience":"human","primary":false,"listed_by":"community","derived_from":"type_data.application_url","on_listing_domain":true},{"kind":"portfolio","url":"https://www.tmc.edu/innovation/portfolio/","audience":"any","primary":false,"listed_by":"community","derived_from":"type_data.portfolio_url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://www.tmc.edu/innovation/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":null,"categories":["Accelerator","Healthcare","MedTech","Digital Health","Biotech","AI in Healthcare","Biomedical Engineering","Oncology"],"stage":null,"founded_year":null,"location":"Houston, USA","pricing":null,"twitter":null,"github":null,"linkedin":"https://www.linkedin.com/company/texas-medical-center-innovation/","contact_email":null,"added_at":"2026-09-04T03:51:21.272Z","added_via":"web","geo":{"keywords":["Accelerator","Startup accelerator","MedTech","Digital Health","AI in Healthcare","Biomedical Engineering","Oncology"],"canonical_facts":["Run by Texas Medical Center","Program duration: 6 months","Cohorts: multiple cohorts per year"]},"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-04T03:51:21.272Z","is_featured":false,"category_memberships":[{"kind":"industry","slug":"accelerator","name":"Accelerator","note":null,"profile_url":"/industries/accelerator"},{"kind":"industry","slug":"ai-in-healthcare","name":"AI in Healthcare","note":null,"profile_url":"/industries/ai-in-healthcare"},{"kind":"industry","slug":"biomedical-engineering","name":"Biomedical Engineering","note":null,"profile_url":"/industries/biomedical-engineering"},{"kind":"industry","slug":"biotech","name":"BioTech","note":null,"profile_url":"/industries/biotech"},{"kind":"industry","slug":"digital-health","name":"Digital Health","note":null,"profile_url":"/industries/digital-health"},{"kind":"industry","slug":"healthcare","name":"Healthcare","note":null,"profile_url":"/industries/healthcare"},{"kind":"industry","slug":"medtech","name":"MedTech","note":null,"profile_url":"/industries/medtech"},{"kind":"industry","slug":"oncology","name":"Oncology","note":null,"profile_url":"/industries/oncology"}],"membership":{"note":null,"source":"listing","added_via":"web","added_at":"2026-09-04T03:51:21.272Z","updated_at":"2026-09-04T03:51:21.272Z"}}],"total":21,"limit":50,"offset":0}